Lyell Immunopharma, Inc. Shares Outstanding (Cover Page)
Lyell Immunopharma, Inc. (LYEL) had Shares Outstanding (Cover Page) of 24.51 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-03: Entity Common Stock, Shares Outstanding 24.51M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 23.33M shares.
- 2026-03-09: Entity Common Stock, Shares Outstanding 23.31M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 21.22M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 24.51M shares 10-Q · filed 2026-08-06 |
| 2026-05-01 | 23.33M shares 10-Q · filed 2026-05-06 |
| 2026-03-09 | 23.31M shares 10-K · filed 2026-03-12 |
| 2025-11-10 | 21.22M shares 10-Q · filed 2025-11-12 |
| 2025-08-07 | 19.21M shares 10-Q · filed 2025-08-12 |
| 2025-05-08 | 295.34M shares 10-Q · filed 2025-05-13 |
| 2025-03-06 | 295.23M shares 10-K · filed 2025-03-11 |
| 2024-11-05 | 279.22M shares 10-Q · filed 2024-11-07 |
| 2024-08-02 | 256.00M shares 10-Q · filed 2024-08-07 |
| 2024-05-02 | 254.94M shares 10-Q · filed 2024-05-06 |
| 2024-02-22 | 254.10M shares 10-K · filed 2024-02-28 |
| 2023-11-02 | 251.87M shares 10-Q · filed 2023-11-07 |
| 2023-08-03 | 251.03M shares 10-Q · filed 2023-08-08 |
| 2023-04-28 | 249.61M shares 10-Q · filed 2023-05-04 |
| 2023-02-24 | 249.61M shares 10-K · filed 2023-02-28 |
| 2022-11-03 | 249.33M shares 10-Q · filed 2022-11-08 |
| 2022-08-01 | 247.83M shares 10-Q · filed 2022-08-04 |
| 2022-05-05 | 246.14M shares 10-Q · filed 2022-05-10 |
| 2022-03-25 | 245.39M shares 10-K · filed 2022-03-29 |
| 2021-11-05 | 240.47M shares 10-Q · filed 2021-11-12 |
| 2021-08-09 | 239.40M shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |